Brivaracetam Tipsheet

The following information is intended for use by providers who are attempting to prescribe Brivaracetam to Biobank participants with certain CYP2C19 genetic variants.  

If you have questions, please call the pharmacogenomics consult pager at (303) 266-4510.

 

Screen Shot 2022-02-09 at 4.07.40 PM

References:

  1. https://www.briviact.com/briviact-PI.pdf
  2. https://www.ncbi.nlm.nih.gov/books/NBK500036/
  3. Moseley BD et al. Epilepsy Res. 2019; 158:106218. PMID: 31675621
Did you find this information useful?